# US 2011/0237542 A1 · Composition for preventing adhesion

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0237542 A1
- Document ID: US20110237542A1
- Status: Published application
- Kind: A1
- Application number: 13/131,996
- Filed: 2009-11-25
- Published: 2011-09-29
- Earliest claimed: 2008-12-01
- Assignees: Shin Poong Pharmaceutical Co., Ltd.; Postech Academy-Industry Foundation
- Inventors: Il Hwan Cho; Sei Kwang Hahn; Eui Jin Hwang; Jang Sik Shin; Junseok Yeom
- Web page: https://patentgrep.com/patent/US20110237542A1

## CPC

- A61K 31/722: Chitin, chitosan
- A61K 31/728: Hyaluronic acid
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 41/00: Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a composition for preventing tissue adhesion which comprising a bio-compatible hyaluronic acid and a polymer compound. More specifically, the invention is a composition containing hyaluronic acid which has not been modified by a chemical crosslinking or other chemical modification a method for preparing the same, and a composition for adhesion prevention with superior efficacy. The composition of the present invention for preventing adhesion exhibits a physical barrier function and a new adhesion prevention function whereby thrombus formation, which is the basis of adhesion, is inhibited. Unlike conventional compositions which simply mixpolymeric substances that function as physical barriers, the present invention performs a more effective role as a physical barrier by undergoing decomposition, absorption and excretion after a certain period inside a human body, does not interfere with healing of scars following surgery, and exhibits superior effects since application to areas of surgery is convenient.

## Claims

### Claim 1

A composition for preventing adhesion comprising a hyaluronic acid and, a hydroxyethyl starch or chitooligosaccharide.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the hyaluronic acid has a molecular weight of 0.8×106 to 3×106 Da.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the content of the hyaluronic acid is in the range of 0.5 to 5.0% by weight, based on the total weight of the composition.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the hydroxyethyl starch has a molecular weight of 2.0×105 to 1.0×106 Da and a molar substitution degree of 0.75 to 0.4.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the hydroxyethyl starch has a molecular weight of 2.5×105 to 6.7×105 Da and a molar substitution degree of 0.75 to 0.4.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein the content of the hydroxyethyl starch is in the range of 0.1% by weight to 2.0% by weight, based on the total weight of the composition.

### Claim 7 (depends on 1)

The composition according to claim 1, wherein the water-soluble chitooligosaccharide has a molecular weight of 1×103 to 5×103 Da.

### Claim 8 (depends on 1)

The composition according to claim 1, wherein the content of the water-soluble chitooligosaccharide is in the range of 0.1% by weight to 10% by weight, based on the total weight of the composition.

### Claim 9 (depends on 1)

The composition according to claim 1, wherein the hyaluronic acid is one extracted from an animal tissue or prepared by a fermentation method.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

A method for preventing a post-operative adhesion of surrounding organs or tissues, comprising administering a composition of claim 1 to a mammal including a human.

### Claim 12 (depends on 2)

A method for preventing a post-operative adhesion of surrounding organs or tissues, comprising administering a composition of claim 2 to a mammal including a human.

### Claim 13 (depends on 3)

A method for preventing a post-operative adhesion of surrounding organs or tissues, comprising administering a composition of claim 3 to a mammal including a human.

### Claim 14 (depends on 4)

A method for preventing a post-operative adhesion of surrounding organs or tissues, comprising administering a composition of claim 4 to a mammal including a human.

### Claim 15 (depends on 5)

A method for preventing a post-operative adhesion of surrounding organs or tissues, comprising administering a composition of claim 5 to a mammal including a human.

### Claim 16 (depends on 6)

A method for preventing a post-operative adhesion of surrounding organs or tissues, comprising administering a composition of claim 6 to a mammal including a human.

### Claim 17 (depends on 7)

A method for preventing a post-operative adhesion of surrounding organs or tissues, comprising administering a composition of claim 7 to a mammal including a human.

### Claim 18 (depends on 8)

A method for preventing a post-operative adhesion of surrounding organs or tissues, comprising administering a composition of claim 8 to a mammal including a human.

### Claim 19 (depends on 9)

A method for preventing a post-operative adhesion of surrounding organs or tissues, comprising administering a composition of claim 9 to a mammal including a human.
